Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
55 results
D2.202 - Threshold of Allergic Reactions to Cashew and Pistachio in a Large Israeli Population
D2.203 - Awareness of and adherence to advice on early introduction of food allergens: is it preventing food allergy? Protocol for EarLY Food Allergens iNTroduction (ELYFANT) study
D2.348 - Clinical Course of Hereditary Angioedema Patients Transitioning off Androgens
D2.402 - Main Pollen Types Identified in Aerobiological Stations of the Latin American Aerobiology Network (Red Latinoamericana de AerobIología, RLA)
D2.47 - Application of magnetic particle chemiluminescence technology to detect sensitization in patients in Guangzhou, China: a study base on real-world medical data
D2.53 - Prevalence of angioedema in the emergency department at Sant Joan De Déu (Manresa)
D2.58 - Relationship between the severity of atopic dermatitis and quality of life in children and adults attending an allergy clinic in Colombia between 2018-2020: A marginal mean weighting through stratification analysis (MMWS)
- D3.134 - Evaluation of the level of asthma control in the pulmonology-phtisiology department of the Ignace Deen University Hospital
D3.16 - Recommendations to travelers with pollen allergy, main pollens identified in aerobiological stations from Perú and Spain
- D3.162 - The Effects of Phthalate Exposure on Asthma via Microbiota Changes
D3.77 - Hypersensitivity Reactions to Iodinated Contrast Media: A Single-Center Experience
D3.139 - Asthma Comorbidities - do they add more cost, A 3-year follow-up study in Réunion Island
D3.314 - Sensitization Profile in Patch Tests with the Portuguese Baseline Series in the Algarve
D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)
D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)
D3.436 - Advancing Equity in Food Allergy Prevention – Insights and Takeaways from CFAAR’s Summit for Advancing Equity in Food Allergy
D3.437 - An EAACI Task Force Initiative for Visualizing Historical Pollen and Spore Calendars in Europe
D3.438 - Advances in Automated Pollen Monitoring in Mediterranean Regions: New Developments from the SYLVA Project in Córdoba (Spain)
D3.439 - On-demand treatment of hereditary angioedema attacks: Assessing self-treatment, outcomes and barriers to early intervention
D1.171 - Preventive Effects of Lactococcus lactis on Ovalbumin-Induced Food Allergy in Mice
Pagination
First page
First
Previous page
Previous
Page
1
Current page
2
Page
3
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download